Drug Module Sequence Verification for Medication Error Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The serially-connected drug combinatorial systems lack a mechanism to ensure correct module assembly order and type, leading to a high probability of medication errors due to their universal design and absence of tray-based safety checks.

Innovation Solution

Implement a system where each module is encoded with a unique binary code using frangible electrical conductors, and a controller housing with integrated circuits to verify the correct module type and sequence through data and address buses, ensuring accurate assembly.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Device complexity

If serially-connected design is used to simplify components and supply chain, then device complexity is reduced, but reliability deteriorates due to lack of configuration safety checks

Engineering Contradiction:
Improvecomponent complexityVSAvoidconfiguration accuracy
Core Design Contradiction:
Device complexityVSReliability

Solution Approach 1:

The patent replaces mechanical tray-based configuration checks with an electronic identification and verification system. Each module incorporates electronic identifiers (such as RFID tags, barcodes, or electronic circuits) that communicate with a controller to verify correct assembly sequence and compatibility, substituting mechanical safety checks with electronic verification mechanisms.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The system implements feedback through electronic verification where the controller reads identification data from each module, compares it against the required configuration sequence, and provides feedback signals to confirm correct assembly or alert operators to errors before drug delivery commences.

Inventive Principle:
Principle #23Feedback

2Ease of manufacture

If universal module design is implemented to minimize component parts, then ease of manufacture improves, but reliability worsens due to inability to prevent incorrect assembly

Engineering Contradiction:
Improvemanufacturing efficiencyVSAvoidassembly correctness
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent replaces mechanical differentiation features (such as unique shapes, sizes, or connection interfaces for different module types) with electronic identification systems. All modules share the same mechanical interface for universal connectivity, while electronic identifiers embedded in each module provide the necessary differentiation information for verification by the controller.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent applies universality by designing all modules with identical mechanical connection interfaces and housing structures, allowing any module to physically connect to any other module in the series. This universal mechanical design simplifies manufacturing and assembly, while electronic identifiers provide the specific identification needed to ensure correct configuration.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Device complexity

If tray-based mechanical safety checks are removed to simplify the system, then device complexity is reduced, but harmful factors increase due to medication error risk

Engineering Contradiction:
Improvesystem structureVSAvoidmedication error risk
Core Design Contradiction:
Device complexityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces mechanical tray-based safety checks with an electronic verification system that uses identifiers on each module and a controller to verify correct assembly sequence, thereby eliminating the need for complex mechanical trays while maintaining or enhancing safety against medication errors.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces an electronic intermediary (the controller with verification logic) that mediates between the physical assembly of modules and the safety verification process. This intermediary reads electronic identifiers, validates the configuration sequence, and prevents operation if errors are detected, replacing the direct mechanical safety checking function of the tray.

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS20250339344A1Medication error detection system
Publication Date: 2025.11.06 BRISTOL MYERS SQUIBB CO
  • US20250339344A1 patent drawing
  • US20250339344A1 patent drawing
  • US20250339344A1 patent drawing

AI summary

Various embodiments are provided herein for checking proper inclusion and sequencing of drug modules in a combinatorial drug delivery device.